Faculty group questions rejection of Prozac critic
Article Abstract:
A decision by the University of Toronto to withdraw a job offer made to a renowned scientist was criticized by the Canadian Association of University Teachers. Dr. David Healy, who has published a critical study of Eli Lilly and Co.'s Prozac medication, had been offered a job at the University of Toronto's Centre for Addiction and Mental Health.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Prozac critic sees U of T job revoked
Article Abstract:
David Healy, a renowned researcher who claimed that Prozac might lead to suicide among some patients, may have been denied a job opportunity at the University of Toronto due to his controversial findings. The university received funding from Eli Lilly and Co., which produces Prozac, for its mental health research institute.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Canadian Air faulted for reaction to rival's strike. Loblaw sets 8th consecutive record
- Abstracts: Videotron to explore options if merger blocked. Caisse sees hard reform path
- Abstracts: Cabinet upholds CRTC decision on satellite TV services. Common currency floated again
- Abstracts: Cost cutting brings record Sobeys profit. Cara makes bid for Second Cup. Second Cup removes For Sale sign
- Abstracts: MFDA plans to be running by July 1. Pyramid scheme draws top IDA fine. Key regulator fills new BMO job